Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research Hair Removal With the 3-msec Alexandrite Laser in Patients With Skin Types IV-VI: Efficacy, Safety, and the Role of Topical Corticosteroids in Preventing Side Effects

21 citations , January 2007 in “Journal of Drugs in Dermatology”

The laser effectively removes hair for skin types IV and V but is less effective for type VI.

research The biology and genetics of curly hair

65 citations , March 2017 in “Experimental Dermatology”

Curly hair is influenced by specific genetic variations.

research Prevention of chemotherapy-induced alopecia in rodent models

27 citations , March 2008 in “Cell stress & chaperones”

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

research The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial

17 citations , May 2019 in “Journal of International Medical Research”

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

research Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia

13 citations , April 2010 in “Journal of dermatological science”

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

research Hair loss during and after breast cancer therapy

12 citations , February 2023 in “Supportive Care in Cancer”

research Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy

11 citations , August 2017 in “Supportive care in cancer”

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

research The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial

4 citations , February 2019 in “Breast Cancer Research and Treatment”

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Impact of a Topical Lotion, CG428, on Permanent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Pilot Randomized Double-Blind Controlled Clinical Trial (VOLUME RCT)

research Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)

3 citations , July 2019 in “Supportive Care in Cancer”

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

research Computational Drug Discovery in Chemotherapy-induced Alopecia via Text Mining and Biomedical Databases

3 citations , April 2019 in “Clinical Therapeutics”

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

← Previous page